3 results
Approved WMOCompleted
The primary objective is to show that eplerenone treatment reduces progression of disease in presymptomatic PLN R14del-carriers
Approved WMOWill not start
The primary objective of this study is to evaluate the efficacy (clinical and MRI) of switching tonatalizumab compared to receiving interferon β1-a or glatiramer acetate.
Approved WMORecruiting
Primary: To investigate the performance of the PAM3(+) device in breast cancer imaging. With the performance we mean:1. The ability to visualize blood vessels and tumors in the mammary gland (PA)2. To extract oxygenation saturation estimations (QPAT…